Skip to main content
Article thumbnail
Location of Repository

The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?

By Jonathan Krell, Adam E Frampton and Justin Stebbing


Tumor infiltrating lymphocytes (TILs) are commonly detected in breast tumors but their bearing on disease outcome is uncertain. The importance of TILs appears to be subtype-specific and varies depending on the histologic characteristics of the tumor. As our understanding of tumorigenesis is increasing the relevance of immunobiology will become apparent

Topics: Commentary
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2009). AH: The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
    2. (2011). AR: Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
    3. (2011). C: The Immune Response to Tumors as a Tool toward Immunotherapy. Clinical & developmental immunology
    4. (2006). Croce CM: MicroRNA signatures in human cancers. Nature reviews Cancer
    5. (2005). Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res
    6. (2006). et al: Type, density, and location Krell et al.
    7. (1988). et al: Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.
    8. (2003). Grubeck-Loebenstein B: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res
    9. (2009). Jr: Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer immunity: a journal of the Academy of Cancer Immunology
    10. (2007). Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.
    11. (2004). Mysliwski A:
    12. (2009). Tagliabue E, Balsari A: FOXP3 expression and overall survival in breast cancer.
    13. (2009). The effects of trastuzumab on
    14. (2010). Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
    15. (2009). Zolnierek A, et al: The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer research

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.